Viveve Medical, Inc. Financial Statements — VIVE Stock

Income Statement	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y
Sales/Revenue/Turnover	6	5	5	1	1	1	1	- -	1	7	15	19	7	5	6
- Cost of Revenue	3	2	2	1	- -	1	1	- -	1	5	8	11	6	5	6
+ Cost of Goods & Services	3	2	2	1	- -	1	1	- -	1	5	8	11	6	5	6
+ Sales & Services Revenue	6	5	5	1	1	1	1	- -	1	7	15	19	7	5	6
Gross Profit	3	3	3	- -	- -	1	1	- -	- -	3	7	7	1	- -	1
- Operating Expenses	6	5	4	3	4	5	5	6	12	21	41	52	31	19	22
+ Research & Development	2	2	1	- -	1	2	2	1	5	8	12	14	9	5	10
+ Other Operating Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Selling, General & Admin	4	3	3	3	2	3	3	4	7	13	29	39	22	14	13
+ Other Operating Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Income (Loss)	-3	-2	-2	-3	-3	-4	-5	-6	-12	-19	-34	-45	-30	-18	-22
- Non-Operating (Income) Loss	- -	- -	- -	- -	4	4	-8	1	- -	1	3	4	12	3	- -
+ Interest Expense, Net	- -	- -	- -	- -	- -	1	- -	1	- -	1	3	4	4	1	1
+ Interest Expense	- -	- -	- -	- -	- -	1	- -	1	- -	1	3	4	4	1	1
- Interest Income	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Non-Op (Income) Loss	- -	- -	- -	- -	3	4	-9	- -	- -	- -	- -	- -	8	2	-1
Pretax Income	-2	-2	-2	-3	-7	-8	3	-6	-12	-20	-37	-49	-42	-22	-22
- (Income) Loss from Affiliates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Income Tax Expense (Benefit)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Income (Loss) from Cont Ops	-2	-2	-2	-3	-6	-8	3	-6	-12	-20	-37	-50	-43	-22	-22
- Net Extraordinary Losses (Gains)	- -	- -	- -	-3	-1	- -	- -	- -	- -	- -	- -	1	1	- -	- -
+ Discontinued Operations	- -	- -	- -	3	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Extraord. & Accounting Changes	- -	- -	- -	-5	-1	- -	- -	- -	- -	- -	- -	1	1	- -	- -
Income (Loss) Incl. MI	-2	-2	-2	-1	-6	-8	3	-6	-12	-20	-37	-51	-43	-22	-22
- Minority Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1	-1	- -	- -
Net Income, GAAP	-2	-2	-2	-1	-6	-8	3	-6	-12	-20	-37	-50	-43	-22	-22
- Other Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Preferred Dividends	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	4	5
Net Income Avail to Common, GAAP	-2	-2	-2	-1	-6	-8	3	-6	-12	-20	-37	-50	-43	-26	-27
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	10
Basic EPS, GAAP	-63,972.97	-52,432.43	-43,945.95	-13,648.65	-155,621.62	-209,675	22,429.49	-2,744.23	-2,474.31	-2,180.76	-2,112.43	-1,609.23	-343.84	-16.56	-2.65
Basic EPS from Cont Ops	-63,972.97	-52,432.43	-43,945.95	-84,027.03	-175,621.62	-209,675	22,429.49	-2,744.23	-2,474.31	-2,180.76	-2,112.43	-1,609.23	-340.8	-13.93	-2.18
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	10
Diluted EPS, GAAP	-63,972.97	-52,432.43	-43,945.95	-13,648.65	-155,621.62	-209,675	22,429.49	-2,744.23	-2,474.31	-2,180.76	-2,112.43	-1,609.23	-343.84	-16.56	-2.65
Diluted EPS from Cont Ops	-63,972.97	-52,432.43	-43,945.95	-84,027.03	-175,621.62	-209,675	22,429.49	-2,744.23	-2,474.31	-2,180.76	-2,112.43	-1,609.23	-340.8	-13.93	-2.18
EBITDA	-3	-2	-2	-3	-3	-4	-5	-6	-12	-19	-33	-44	-29	-17	-20
EBITDA Margin (%)	-44.94	-36.85	-32.54	-539.18	-507.15	-377.96	-365.07	-6,228.89	-823.29	-260.37	-217.69	-238.59	-437.87	-313.89	-317.68
EBITA	-3	-2	-2	-3	-3	-4	-5	-6	-12	-19	-34	-45	-30	-18	-22
EBIT	-3	-2	-2	-3	-3	-4	-5	-6	-12	-19	-34	-45	-30	-18	-22
Gross Margin (%)	56.11	58.72	55.47	-11.75	36.51	49.91	58.32	44.44	31.93	35.42	48.69	39.53	15.47	5.4	9.65
Operating Margin (%)	-46.75	-39.57	-34.58	-546.34	-508.49	-381.94	-369.23	-6,291.11	-828.61	-261.92	-220.63	-242.83	-455.87	-337.56	-335.4
Profit Margin (%)	-39.42	-36.4	-34.51	-86.03	-858.12	-776.57	274.65	-6,866.67	-858.74	-281.63	-241.75	-269.92	-647.57	-399.98	-342.78
Sales per Employee	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Depreciation Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1

Balance Sheet	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y
Total Current Assets	11	8	5	3	4	1	2	2	11	14	32	42	22	12	22
+ Accounts & Notes Receiv	1	1	1	- -	- -	- -	1	- -	1	2	6	6	2	1	1
+ Accounts Receivable, Net	1	1	1	- -	- -	- -	1	- -	1	2	6	6	2	1	1
+ Loans Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Notes Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Receivable, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash, Cash Equivalents & STI	8	5	3	1	3	- -	1	1	7	8	21	30	13	7	19
+ Cash & Cash Equivalents	8	5	3	1	3	- -	1	1	7	8	21	30	13	7	19
+ ST Investments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inventories	1	1	1	- -	- -	- -	- -	- -	2	3	2	4	5	3	1
+ Inventory Adjustments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	3	4	3	1
+ Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Raw Materials	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -
+ Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	2	3	2	- -	- -	- -	- -
+ Other ST Assets	1	1	1	1	- -	- -	- -	1	1	1	3	3	2	1	1
+ ST Assets Held-for-Sale	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Prepaid Expenses	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	4	5	5	5	4
+ LT Investments & Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	1	1	1
+ LT Investments	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	2	2	1	1	1
+ LT Receivables	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Property, Plant & Equip, Net	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	3	3	3	2
- Accumulated Depreciation	2	2	2	1	1	1	1	- -	- -	- -	1	2	2	3	3
+ Property, Plant & Equip	2	2	2	1	1	1	1	- -	1	1	2	4	5	6	4
+ Other LT Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	2
+ LT Deferred Tax Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ LT Derivative & Hedging Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Goodwill	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	2
Total Assets	11	8	5	3	4	1	2	2	11	15	36	47	27	17	26
+ Payables & Accruals	2	1	1	1	- -	1	1	1	2	4	9	10	5	3	4
+ Other Payables & Accruals	1	1	1	- -	- -	- -	1	- -	1	1	4	6	4	2	2
+ Accounts Payable	1	- -	- -	- -	- -	- -	- -	- -	1	3	5	4	2	1	1
+ Interest & Dividends Payable	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Accrued Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ ST Debt	- -	- -	- -	- -	- -	- -	- -	2	4	2	- -	- -	- -	1	- -
+ ST Borrowings	- -	- -	- -	- -	- -	- -	- -	2	4	2	- -	- -	- -	1	- -
+ ST Finance Leases	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other ST Liabilities	2	2	2	1	- -	- -	- -	- -	1	1	- -	1	1	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc ST Liabilities	- -	- -	- -	1	- -	- -	- -	- -	1	1	- -	- -	- -	- -	- -
+ Deferred Revenue	2	2	2	- -	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -
Total Current Liabilities	4	3	3	2	1	1	1	3	7	7	9	11	6	4	5
+ LT Debt	- -	- -	- -	- -	5	8	5	- -	- -	8	29	31	4	5	5
+ LT Borrowings	- -	- -	- -	- -	5	8	5	- -	- -	8	29	31	4	5	5
+ LT Finance Leases	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other LT Liabilities	2	1	- -	- -	2	4	3	- -	- -	- -	- -	1	- -	- -	1
+ Accrued Liabilities	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Tax Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Derivatives & Hedging	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Revenue	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Misc LT Liabilities	2	- -	- -	- -	2	4	3	- -	- -	- -	- -	1	- -	- -	1
+ Pension Liabilities	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Noncurrent Liabilities	2	1	- -	- -	7	12	7	- -	- -	8	29	31	4	5	6
Total Liabilities	6	5	3	2	8	13	8	3	7	15	39	42	10	10	11
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Share Capital & APIC	94	94	95	95	95	95	97	35	52	68	103	160	214	227	257
+ Additional Paid in Capital	94	94	95	95	95	95	97	35	52	68	103	160	214	227	257
+ Common Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Treasury Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Retained Earnings	-89	-91	-92	-93	-99	-107	-104	-36	-49	-69	-106	-155	-198	-220	-242
+ Other Equity	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Equity Before Minority Interest	5	3	2	1	-4	-12	-7	-1	4	- -	-3	5	17	7	15
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Equity	5	3	2	1	-4	-12	-7	-1	4	- -	-3	5	17	7	15
Total Liabilities & Equity	11	8	5	3	4	1	2	2	11	15	36	47	27	17	26
Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	2	11
Capital Leases - Total	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Debt	-8	-5	-3	-1	3	8	4	2	-3	2	8	1	-9	-1	-14
Net Debt to Equity	-162.83	-157.51	-155.35	-92.33	-67.07	-65.62	-56.73	-190.84	-74.03	-380.99	-316.08	20.46	-56.44	-9.49	-93.18
Tangible Common Equity Ratio	44.2	40.33	34.29	43.26	-115.19	-1,095.05	-426.32	-36.6	35.44	-2.78	-7.21	10.49	61.24	41.94	58.14
Current Ratio	2.82	2.25	1.64	1.65	4.94	0.89	1.54	0.62	1.5	1.95	3.41	3.89	3.52	2.75	4.91
Cash Conversion Cycle	115.95	159.03	171.23	-785.45	137.24	88.23	-81.83	-462.85	246.47	92.82	26.58	99.4	335.01	236.76	78.93
Number of Employees	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Cash Flow Statement	2007 Y	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y
+ Net Income	-2	-2	-2	-3	-6	-8	3	-6	-12	-20	-37	-50	-43	-22	-22
+ Depreciation & Amortization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1	1	1	1
+ Non-Cash Items	- -	- -	- -	- -	2	5	-8	1	1	2	3	6	12	6	4
+ Asset Impairment Charge	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Deferred Income Taxes	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Non-Cash Adj	- -	- -	- -	-1	3	4	-8	1	1	1	1	3	10	3	- -
+ Stock-Based Compensation	- -	- -	- -	- -	- -	1	- -	- -	- -	1	2	3	2	3	4
+ Chg in Non-Cash Work Cap	- -	-1	-1	- -	- -	1	- -	-1	-1	- -	-1	- -	-2	- -	4
+ (Inc) Dec in Accts Receiv	- -	- -	- -	- -	- -	- -	- -	- -	-1	-1	-4	- -	3	- -	- -
+ Inc (Dec) in Accts Payable	- -	-1	- -	- -	- -	- -	- -	- -	2	3	4	1	-4	-3	1
+ (Inc) Dec in Inventories	- -	- -	- -	- -	- -	- -	- -	- -	-1	-1	- -	-2	-1	1	2
+ (Inc) Dec in Prepaid Assets	- -	- -	- -	- -	- -	- -	- -	- -	-1	- -	-2	- -	- -	- -	- -
+ Inc (Dec) in Other	- -	-1	-1	- -	- -	- -	- -	- -	- -	- -	- -	1	-1	1	1
+ Net Cash From Disc Ops	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Operating Activities	-2	-3	-2	-1	-3	-3	-5	-6	-12	-18	-35	-43	-31	-15	-13
+ Change in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1	-2	-1	-1	- -
+ Acq of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Acq of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1	-2	-1	-1	- -
+ Disp in Fixed & Intang	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Fixed Prod Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Disp of Intangible Assets	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Change in LT Investment	4	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2	- -	- -	- -	- -
+ Dec in LT Investment	4	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Inc in LT Investment	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-2	- -	- -	- -	- -
+ Net Cash From Acq & Div	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for Acq of Subs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash from Divestitures	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Cash for JVs	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Other Investing Activities	- -	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Investing Activities	4	- -	- -	- -	1	- -	- -	- -	- -	- -	-3	-2	-1	-1	- -
+ Dividends Paid	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Net Cash From Debt	- -	- -	- -	- -	4	1	- -	2	5	10	38	- -	- -	1	- -
+ Cash From Debt	- -	- -	- -	- -	4	1	- -	4	5	20	58	- -	- -	1	- -
+ Repayments of Debt	- -	- -	- -	- -	- -	- -	- -	-2	- -	-10	-20	- -	- -	- -	- -
+ Cash (Repurchase) of Equity	- -	- -	- -	- -	- -	- -	- -	4	16	14	32	54	16	- -	26
+ Decrease in Capital Stock	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Increase in Capital Stock	- -	- -	- -	- -	- -	- -	- -	4	16	14	32	54	16	- -	26
+ Other Financing Activities	- -	- -	- -	- -	- -	- -	5	- -	-2	-5	-19	- -	- -	8	- -
+ Net Cash From Disc Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash from Financing Activities	- -	- -	- -	- -	4	1	5	7	19	19	51	54	16	9	26
Effect of Foreign Exchange Rates	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Changes in Cash	2	-3	-2	-1	1	-2	1	- -	6	1	13	9	-16	-7	13
Capital Expenditures	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-1	-2	-1	-1	- -
EBITDA	-3	-2	-2	-3	-3	-4	-5	-6	-12	-19	-33	-44	-29	-17	-20
EBITDA Margin (%)	-44.94	-36.85	-32.54	-539.18	-507.15	-377.96	-365.07	-6,228.89	-823.29	-260.37	-217.69	-238.59	-437.87	-313.89	-317.68
Net Cash Paid for Acquisitions	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow	-2	-3	-2	-1	-3	-3	-5	-6	-12	-18	-36	-45	-32	-16	-13
Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	-4	- -	- -	- -	- -	- -	- -	- -	- -
Free Cash Flow to Equity	-2	-3	-2	-1	- -	-2	-5	-4	-8	-8	3	-45	-33	-19	-18
Free Cash Flow per Basic Share	-54,135.14	-81,000	-64,135.14	-36,432.43	-92,189.19	-80,975	-30,794.87	-2,712.26	-2,450.02	-1,989.05	-2,043.78	-1,456.33	-259.03	-10.18	-1.32
Price/Free Cash Flow	- -	- -	- -	-14,492.58	-9,208.89	-13,458.43	-9,352.21	-13,801.84	-28,089.29	-26,635.24	-25,614.21	-7,964.24	-521.5	-5,116.99	-9,259.61
Cash Flow to Net Income	0.76	1.53	1.46	2.67	0.59	0.38	-1.37	0.97	0.98	0.9	0.94	0.86	0.73	0.7	0.58

Viveve Medical, Inc.

Income Statement

Balance Sheet

Cash Flow Statement